International Society for Research on Psychedelics

Virtual Research Conference Agenda
March 7th 2025
11:00 AM - 6:30 Eastern Daylight Time (EDT)
8:00 AM - 3:30 PM Pacific Daylight Time (PDT)

• Welcome & Opening Remarks

Time: 11:00 AM EDT / 8:00 AM PDT
Duration: 10 minutes

• Pre-Clinical Presentations - Block 1

Time: 11:10 AM EDT / 8:10 AM PDT
Duration: 1 hour 20 minutes

—

11:10 AM - 11:25 AM EDT
8:10 AM - 8:25 AM PDT
The atypical psychedelic Ibogaine facilitates plastic changes in monocularly deprived mice
Alejo Acuña

11:25 AM - 11:40 AM EDT
8:25 AM - 8:40 AM PDT
Cerebral serotonin 2A receptor occupancy of psychedelic and non-psychedelic compounds as measured in vivo in pigs
Clara Madsen

11:40 AM - 11:55 AM EDT 
8:40 AM - 8:55 AM PDT
The structural diversity of psychedelic drug actions revealed
Ryan Gumpper

11:55 AM - 12:10 PM EDT 
8:55 AM - 9:10 AM PDT
Developing animal models of psychedelic therapy: Methods and mechanisms for reversal of trauma-induced behavior in rats
Kate Lawson

12:10 PM - 12:25 PM EDT
9:10 AM - 9:25 AM PDT
N,N-dimethyltryptamine (DMT) pharmacodynamic effects and pharmacokinetics after intranasal administration in male rats
Michael Baumann

12:25 PM - 12:40 PM EDT
9:25 AM - 9:40 AM PDT
Psychedelic drugs induce the formation of new synapses in the cochlea
Uri Manor

12:40 PM - 12:55 PM EDT
9:40 AM - 9:55 AM PDT
Investigation of 5HT2AR using super resolution microscopy
Blake Fordyce

12:55 PM - 1:10 PM EDT 
9:55 AM - 10:10 AM PDT
Novel 5-MeO-DMT analogues with anxiolytic activity
Sam Banister

• Break

Time: 1:10 PM EDT / 10:10 AM PDT
Duration: 15 minutes

• Pre-Clinical Presentations - Block 2

Time: 1:30 PM EDT / 10:30 AM PDT
Duration: 1 hour 30 minutes

 —

 1:30 PM - 1:45 PM EDT 
10:30 AM - 10:45 AM PDT
Pharmacological and pharmacokinetic characterization of 6-F-DET
Will Jorgensen

1:45 PM - 2:00 PM EDT
10:45 AM - 11:00 AM PDT
The classical psychedelic psilocybin mitigates oxycodone withdrawal
M. Imad Damaj

2:00 PM - 2:15 PM EDT 
11:00 AM - 11:15 AM PDT
Ayahuasca’s psychedelic component DMT promotes neuritogenesis in PC12 cells
Mariana Pazos

2:15 PM - 2:30 PM EDT 
11:15 AM - 11:30 AM PDT
Structural insights into the psychoactivity of tryptamines: conformational analysis, permeability, and MAO metabolism
David Lankri

2:30 PM - 2:45 PM EDT
11:30 AM - 11:45 AM PDT
Pre-administration of lorazepam negates the antidepressant-like effects of psilocybin in male Wistar Kyoto rats
Sophie Woodruff

2:45 PM - 3:00 PM EDT
11:45 AM - 12:00 PM PDT
Psilocybin effect on monoaminergic and amino acid neurotransmitter release in the chronically stressed rats
Agnieszka Bysiek

• Break

Time: 3:00 PM EDT / 12:00 PM PDT
Duration: 15 minutes

• Pre-Clinical/Observational

Time: 3:15 PM EDT / 12:15 PM PDT
Duration: 1 hour

— 

3:15 PM - 3:30 PM EDT
12:15 PM - 12:30 PM PDT
Serotonin transporter activity modulates the psychedelic-like effects of 4-methoxy-N-methyl-N-isopropyltryptamine and related analogs in mice
Grant Glatfelter

3:30 PM - 3:45 PM EDT
12:30 PM - 12:45 PM PDT
Determination of Psilocin and Psilocybin by Quantitative Nuclear Magnetic Resonance in Psychedelic Mushrooms from Uruguay
Luisina Rodriguez

3:45 PM - 4:00 PM EDT
12:45 PM - 1:00 PM PDT
As time goes by: the impact of drying and preservation methods on mushroom’s tryptamine content
Guillermo Morera

4:00 PM - 4:15 PM EDT
1:00 PM - 1:15 PM PDT
Exploring the potential of psychedelics as a treatment for methamphetamine addiction
Kevin Murnane

• Observational Research Presentations

Time: 4:15 PM EDT / 1:15 PM PDT
Duration: 1 hour 15 minutes

—

4:15 PM - 4:30 PM EDT
1:15 PM - 1:30 PM PDT
The Open Psilocybin Evaluation Nexus (OPEN): initial findings from a practice-based research network studying state-regulated psilocybin services
Jason Luoma

4:30 PM - 4:45 PM EDT
1:30 PM - 1:45 PM PDT
Psychedelics and psychological strengths
David Rosen

4:45 PM - 5:00 PM EDT
1:45 PM - 2:00 PM PDT
Co-use of psychedelics with other substances: findings from the global psychedelic survey
Philippe Lucas

5:00 PM - 5:15 PM EDT
2:00 PM - 2:15 PM PDT
Minimal variance across session facilitators on psilocybin's acute subjective effects
Sean Goldy

5:15 PM - 5:30 PM EDT
2:15 PM - 2:30 PM PDT
Generalized psychedelic efficacy hypothesis
Matthew Johnson

• Break

Time: 5:30 PM EDT / 2:30 PM PDT
Duration: 15 minutes

• Clinical Studies Presentations

Time: 5:45 PM EDT / 2:45 PM PDT
Duration: 1 hour

— 

5:45 PM - 6:00 PM EDT
2:45 PM - 3:00 PM PDT
Are psychedelics anti-inflammatory? A systematic review and meta-analysis of studies examining the immunomodulatory effects of serotonergic psychedelics
D. Parker Kelley

6:00 PM - 6:15 PM EDT
3:00 PM - 3:15 PM PDT
Psilocybin with psychological support for treatment-resistant depression: a pilot clinical trial
Sally Meikle

6:15 PM - 6:30 PM EDT
3:15 PM - 3:30 PM PDT
Psychedelic symphonies: investigating LSD and music-induced brain activity using fMRI
Peter Skov-Andersen

6:30 PM - 6:45 PM EDT
3:30 PM - 3:45 PM PDT
Acute psychedelic effects and measures of mental health are not related to headache frequency changes in clinical trials of psilocybin in migraine and cluster headache
Emmanuelle Schindler

• Closing Remarks & Thanks

Time: 6:45 PM EDT / 3:45 PM PDT
Duration: 5-10 minutes